Melphalan (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Melphalan" in English language version.

refsWebsite

Global rank English rank

4fda.gov

447^th place

338^th place

3doi.org

2^nd place

3nih.gov

4^th place

2europa.eu

68^th place

117^th place

2drugs.com

399^th place

333^rd place

1tga.gov.au

3,984^th place

2,622^nd place

1handle.net

102^nd place

76^th place

1prnewswire.com

406^th place

258^th place

1cancer.gov

1,684^th place

1,350^th place

cancer.gov

"Melphalan". National Cancer Institute. Retrieved 4 August 2014.

doi.org

Bergel F, Stock JA (1954). "Cyto-active amino-acid and peptide derivatives. Part I. Substituted phenylalanines". Journal of the Chemical Society (Resumed): 2409. doi:10.1039/JR9540002409.
Bergel F, Burnop VC, Stock JA (1955). "Cyto-active amino-acids and peptides. Part II. Resolution of para-substituted phenylalanines and synthesis of p-di-(2-chloroethyl)amino-DL-phenyl[?-14C]alanine". Journal of the Chemical Society (Resumed): 1223–1230. doi:10.1039/JR9550001223.
Larionov LF, Khokhlov AS, Shkodinskaja EN, Vasina OS, Troosheikina VI, Novikova MA (1955). "Studies on the anti-tumour activity of p-di-(2-chloroethyl) aminophenylalanine (sarcolysine)". Lancet. 266 (6882): 169–71. doi:10.1016/S0140-6736(55)92736-7. PMID 13243678.

drugs.com

"Melphalan Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 9 October 2019.
"Melphalan Use During Pregnancy". Drugs.com. Retrieved 9 October 2019.

europa.eu

ema.europa.eu

"Phelinun EPAR". European Medicines Agency (EMA). 15 September 2020. Retrieved 23 April 2022. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Phelinun: Pending EC decision". European Medicines Agency (EMA). 18 September 2020. Retrieved 21 September 2020. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

fda.gov

accessdata.fda.gov

https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201848s000lbl.pdf ^{[bare URL PDF]}
"Evomela (Captisol-enabled melphalan HCl) for Injection". U.S. Food and Drug Administration (FDA). 30 November 2016. Retrieved 7 September 2023.

nctr-crs.fda.gov

"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 October 2023.

fda.gov

"Oncology (Cancer) / Hematologic Malignancies Approval Notifications". U.S. Food and Drug Administration (FDA). 14 August 2023. Retrieved 7 September 2023. This article incorporates text from this source, which is in the public domain.

handle.net

hdl.handle.net

World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

nih.gov

dailymed.nlm.nih.gov

"Alkeran- melphalan tablet, film coated". DailyMed. 18 November 2019. Retrieved 23 April 2022.
"Evomela- melphalan injection, powder, lyophilized, for solution". DailyMed. 31 December 2021. Retrieved 23 April 2022.

pubmed.ncbi.nlm.nih.gov

Larionov LF, Khokhlov AS, Shkodinskaja EN, Vasina OS, Troosheikina VI, Novikova MA (1955). "Studies on the anti-tumour activity of p-di-(2-chloroethyl) aminophenylalanine (sarcolysine)". Lancet. 266 (6882): 169–71. doi:10.1016/S0140-6736(55)92736-7. PMID 13243678.

prnewswire.com

"Delcath Systems, Inc. Announces FDA Approval of Hepzato Kit for the Treatment of Adult Patients with Unresectable Hepatic-Dominant Metastatic Uveal Melanoma" (Press release). Delcath Systems. 14 August 2023. Retrieved 7 September 2023 – via PR Newswire.

tga.gov.au

"Prescription medicines: registration of new generic medicines and biosimilar medicines, 2017". Therapeutic Goods Administration (TGA). 21 June 2022. Retrieved 30 March 2024.